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Parental imprinting is an epigenetic phenomenon by which genes are expressed in a monoallelic fashion, according to their parent of
origin. DNA methylation is considered the hallmark mechanism regulating parental imprinting. To identify imprinted differentially
methylated regions (DMRs), we compared the DNA methylation status between multiple normal and parthenogenetic human pluripo-
tent stem cells (PSCs) by performing reduced representation bisulﬁte sequencing. Our analysis identiﬁed over 20 previously unknown
imprinted DMRs in addition to the known DMRs. These include DMRs in loci associated with human disorders, and a class of intergenic
DMRs that do not seem to be related to gene expression. Furthermore, the study showed some DMRs to be unstable, liable to differen-
tiationorreprogramming.AcomprehensivecomparisonbetweenmouseandhumanDMRsidentiﬁedalmosthalfoftheimprintedDMRs
to be species speciﬁc. Taken together, our data map novel DMRs in the human genome, their evolutionary conservation, and relation to
gene expression.
INTRODUCTION
Parental imprinting is a form of epigenetic regulation by
which genes are expressed from only one of the two
parental alleles. In humans, loss of imprinting is associated
with several diseases (e.g., Prader-Willi/Angelman syn-
dromes) and malignancies (e.g., Wilm’s tumor) (Yamazawa
et al., 2010). The generation of mouse embryos containing
only maternal (parthenogenetic) or paternal (androge-
netic)alleles(McGrathandSolter,1984;SuraniandBarton,
1983; Surani et al., 1984) demonstrated the importance of
imprinting for restricting asexual form of reproduction in
placental mammals. Parthenogenesis may occur naturally
inhumansresultinginparthenogeneticovarianteratomas.
We have recently generated human-parthenogenetic-
induced pluripotent stem cells (PgHiPSCs) by reprogram-
ming of parthenogenetic ovarian teratomas (Stelzer et al.,
2011). Studying the gene expression of PgHiPSCs enabled
us to identify novel paternally expressed genes (PEGs),
and to study the developmental potential of these cells
(Stelzer et al., 2011). Differential marking of DNA methyl-
ationinthegametesisconsideredthehallmarkmechanism
controlling parental imprinting as it establishes germline
DMRs (gDMRs), which are then maintained throughout
the life of the embryo (Proudhon et al., 2012; Reik et al.,
2001; Smith et al., 2012). In the past few years, global sur-
veys of imprinted DMRs in the mouse were reported (Hiura
etal.,2010;Kelseyetal.,1999;Proudhonetal.,2012;Singh
et al., 2011), and recently DNA methylation analysis at
single-base resolution, performed on reciprocal crosses of
inbred-mice, identiﬁed dozens of novel DMRs (Xie et al.,
2012). In humans, however, due to ethical and technical
limitations, only few low-resolution surveys were achieved
thusfar(Choufanietal.,2011).Moreover,thevastmajority
of DMRs in humans were identiﬁed by association with
certain diseases or by sharing synteny with mouse DMRs.
In this study, we aimed to perform a comprehensive anal-
ysis of imprinted DMRs in humans. We thus analyzed
global DNA methylation of our PgHiPSCs and their
parental ﬁbroblasts by reduced representation bisulﬁte
sequencing (RRBS) (Gu et al., 2011; Meissner et al., 2008)
and compared the methylation signature to that of a large
panelofhumanembryonicstemcells(HESCs)andinduced
pluripotent stem cells (HiPSCs) (Bock et al., 2011).
RESULTS
Analysis of Known Imprinted DMRs in Human
Pluripotent Stem Cells
Parthenogenetic cells lack the paternal allele and are there-
fore expected to exhibit differential methylation patterns
in imprinted DMRs when compared to normal biparental
cells. Notably, comparing the DNA methylation signature
can equally identify maternal DMRs (mDMRs), which are
expected to show hypermethylation and paternal DMRs
(pDMRs), which will exhibit hypomethylation when
compared to normal cells (Figure S1A available online).
Recently,asimilarapproachwasusedtoidentifyepigenetic
variationofknownimprintedDMRs(Nazoretal.,2012).To
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PgHiPSCs, we performed RRBS on four iPSC lines derived
fromtwoindependentparthenogeneticteratomacelllines,
which were shown to exhibit a complete homozygote
diploid genome (Stelzer et al., 2011). Similar analysis was
performed on the parental parthenogenetic teratoma cell
lines. The data were then ﬁltered and evaluated through
bioinformatic analysis (Bock et al., 2010), yielding high-
coverage reads and reproducible results (Figure S1B). We
next compared the global DNA methylation proﬁles of
PgHiPSCs, their parental cells with previously published
data sets including 20 samples of HESCs, 12 samples of
HiPSCs, and six samples of normal human ﬁbroblasts
(Bock et al., 2011). This large data set of undifferentiated
and differentiated cells has previously enabled the identiﬁ-
cationofepigenetic changesassociatedwith Xinactivation
(Mekhoubad et al., 2012) and was now utilized as a refer-
ence for a comprehensive study of epigenetic changes asso-
ciated with parental imprinting in the different cell types.
Unsupervised hierarchical clustering demonstrated that
the undifferentiated pluripotent stem cells share a distinct
epigenetic signature, which distinguishes them from
mature parthenogenetic and normal somatic cells (Fig-
ure S2A). We then analyzed the status of methylation of
known imprinted DMRs (Table 1). Since loss of imprinting
is associated with disease and malignancies, perturbations
in imprinted DMRs may affect the therapeutic potential
ofHESCs.Wethereforestudiedtheheterogeneityofknown
imprinted DMRs in HESCs (Figure 1A). While most of the
DMRs examined maintain stable hemimethylation values
in wild-type samples (average methylation calls [AMCs] be-
tween 0.3 and 0.7), few DMRs (PEG3, DIRAS3, and ZDBF2)
show more variable values in the pluripotent stem cells.
This effect does not seem to correlate with culture
passagingasthevariabilitywasevidenteveninlow-passage
HESCs (Figure S2B). We next asked whether reprogram-
ming of somatic cells to pluripotency affects the methyl-
ation levels of known DMRs. In agreement with our
previous study on the stability of imprinted genes in
HiPSCs (Pick et al., 2009), the vast majority of DMRs main-
tain hemimethylation values, thus demonstrating striking
similarities between HiPSCs and HESCs (Figure 1B).
However, the three DMRs that exhibit the highest levels
of variation in HESCs show loss of imprinting in HiPSCs
and are consistently hypermethylated in these cells. This
can be due to loss of imprinting in the parental ﬁbroblasts,
or, alternatively, imply that these DMRs are more suscepti-
ble to aberrant methylation during reprogramming. To
distinguish between the two options, we examined the
methylation levels of these DMRs in the parental somatic
cells (Figure S2C). Our results show that, while PEG3 and
DIRAS3 DMRs exhibit loss of imprinting already in the
parental cells, the ZDBF2 DMR may be prone to perturba-
tions that are due to the reprogramming process. Studying
the methylation levels of DMRs in 16-day-old embryoid
bodies (EBs), that were differentiated from HESCs, further
emphasized that in vitro differentiation resulted in loss of
the DMR in DIRAS3 and PEG3 sites (Figure 1C). We next
compared the methylation levels of known DMRs between
PgHiPSCs and HESCs. Unlike normal HiPSCs, the parthe-
nogenetic HiPSCs can be distinguished from HESCs in
virtually all imprinted DMRs examined (Figure 1D), and
are either hypermethylated (AMC >0.7) or hypomethy-
lated (AMC <0.3) in comparison to the hemimethylation
state of the HESCs (AMC between 0.3 and 0.7). For
example, the two well-studied imprinted DMR loci
Table 1. Analysis of Previously Identiﬁed Human Imprinted
DMRs
Chromosome Locus CGI
Diff
(ES-PG)
Parent of
Origin
chr1 DIRAS3 Yes 0.12 M
chr2 ZDBF2 Yes 0.22 P
chr6 PLAGL1 No 0.20 M
chr7 GRB10 Yes 0.29 M
chr7 PEG10/SGCE No 0.51 M
chr7 MEST Yes 0.27 M
chr10 INPP5F Yes 0.25 M
chr11 H19 Yes 0.21 P
chr11 H19 – ICR Yes 0.38 P
chr11 IGF2 DMR1 No 0.12 P
chr11 KCNQ1OT1 Yes 0.23 M
chr14 MEG3 No 0.35 P
chr15 AS-ICR Yes 0.48 M
chr15 SNURF-SNRPN Yes 0.47 M
chr16 NAT15,ZNF597 Yes 0.30 P
chr19 PEG3 Yes 0.14 M
chr20 BLCAP,NNAT Yes 0.16 M
chr20 L3MBTL Yes 0.23 M
chr20 GNASXL Yes 0.19 M
chr20 NESPAS No 0.57 M
chr20 GNAS1A Yes 0.21 M
chr20 GNAS1A - exon 1 No 0.13 M
ListofpreviouslyidentiﬁedimprintedDMRs.CGI,CpGisland;M,maternal;P,
paternal. See also Figure S3.
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Imprinted DMRs in Parthenogenetic iPS CellsKCNQ1OT and IGF2-H19 are either hypermethylated
(mDMR, Figure 1E) or hypomethylated (pDMR, Figure 1F)
in the PgHiPSCs, in comparison to being hemimethylated
in the biparental cells.
Genome-wide Search for Novel Imprinted DMRs
In order to identify novel imprinted DMRs throughout the
genome, we ﬁrst veriﬁed the integrity of our data by study-
ing the methylation values of previously discovered DMRs.
Out of 22 well-established imprinted DMRs, 18 are either
hypermethylated or hypomethylated in the PgHiPSCs in
comparison to HESCs (methylation difference >0.15). Of
the four known DMRs that could not be identiﬁed in our
analysis, three also show loss of imprinting in the normal
PSCs (e.g., PEG3), and one lost the imprint upon reprog-
ramming of the parthenogenetic somatic cells into
PgHiPSCs (e.g., GNAS, Figures S2D and S2E, respectively).
We next searched for hemimethylation regions in both
HESCs and HiPSCs and compared them to the methylation
status in PgHiPSCs. In addition, we focused on regions in
which the difference in DNA methylation levels between
PgHiPSCs and HESCs was greater than 0.2 (see Experi-
mental Procedures). Aberrant changes in DNA methyl-
ation, arising during the establishment of HiPSCs, are a
major concern when aiming to identify epigenetic differ-
ences between normal and parthenogenetic PSCs. We
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Figure 1. Genome-wide Analysis of
Imprinted DMRs in PSCs
(A) Box-plot analysis showing distribution
of DNA methylation in 20 HESCs lines in
known imprinted DMRs. DMRs are ordered
according to the levels of heterogeneity
(x axis).
(B–D) Average methylation calls ± SE of
different cell types in known imprinted
DMRs. DMRs are ordered by chromosome
numbers (x axis); small arrows pointing to
DMRs that are perturbed in the different cell
types.
(E and F) Regional view of KCNQ1 and H19
known DMR. Average methylation values for
wild-type PSCs (blue) and PgHiPSCs (red) of
all CpG calls. Green track indicates the dif-
ference between hemimethylated (AMC be-
tween 0.3 and 0.7) wild-type PSCs and
PgHiPSCs CpGs. Shown are signiﬁcant pu-
tative CTCF binding sites in H1 ES cells from
the ENCODE project (depicted in black
rectangles, p value < 1 3 10
 5) and CpG
islands (UCSC) in dark-blue rectangles.
See also Figures S1 and S2.
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different sources. Furthermore, we ﬁltered out regions of
recurrent aberrant reprogramming, which were previously
mapped in iPS cell lines derived from distinct tissues (Lister
et al., 2011). This analysis identiﬁed 21 novel DMRs: eight
of which are located in well-known imprinted regions
(three of which are in the Prader-Willi/Angelman region),
three are known to be imprinted in mice, and two appear
in a cluster, a common phenomenon for imprinted genes
(Ferguson-Smith, 2011)( Table 2, permutation test, p
value = 0.011). These clustered DMRs are ofspeciﬁc interest
as they reside in the Neuroblastoma breakpoint family
(NBPF), suggesting that parental imprinting may be
involved in the acquisition of the disease. Eight novel
DMRs appear in regions not previously suggested to be im-
printed. This type of novel DMR had good sequencing
coverage and showed high levels of consistency between
different samples of the same cell type (Table 2, permuta-
tion test, p value = 0.0059, see Experimental Procedures).
To link between DNA methylation and gene expression
on a genome-wide scale, we performed RNA sequencing
(RNA-seq) in two independent PgHiPSC lines and two
normal HESC and HiPSC lines. Our experiment yielded
highly reproducible results and deep coverage reads.
Parthenogenetic cells lack the paternal genome and conse-
quently PEGs are expected to show downregulation when
compared to normal biparental cells. Interestingly, we
could identify ﬁve differentially expressed genes between
PgHiPSCs and normal PSCs within 200 kb of the novel
DMRs, strengthening the notion that they are potentially
Table 2. Human Imprinted DMRs Identiﬁed in This Study
Chromosome Locus CGI Diff
Parent of
Origin
Differential
Gene Expression
DMRs in known imprinted regions chr11 TH,ASCL2 Yes 0.45 P Yes
chr14 DIO3 Yes 0.31 P No
chr15 WHAMMP3,NIPA1 Yes 0.23 P No
chr15 PWRN2 Yes 0.23 P No
chr15 LOC100289656 Yes 0.27 P No
chr16 FLYWCH1 Yes 0.23 M Yes
chr20 L3MBTL No 0.26 M No
chr20 GNAS Yes 0.27 M No
DMRs syntenic to mouse chr8 TRAPPC9 Yes 0.30 M No
chr15 NDN Yes 0.22 M Yes
chr15 MAGEL2 Yes 0.37 M Yes
DMRs in clusters chr1 NBPF Yes 0.20 P No
chr1 NBPF Yes 0.29 P No
DMRs in unknown regions chr1 TMEM51 Yes 0.38 M Yes
chr5 TSPAN17,UNC5A Yes 0.51 P No
chr7 TMEM176A/ B No 0.30 P Yes
chr9 RCL1 Yes 0.41 P No
chr9 ZNF322B Yes 0.31 M No
chr10 INPP5A Yes 0.22 M Yes
chr13 TSC22D1 No 0.31 M No
chr17 MIR301A No 0.43 M Yes
List of new imprinted DMRs identiﬁed in this study. CGI, CpG island; M, maternal; P, paternal; Diff, difference in DNA methylation values between normal
HESCsandPgHiPSCs.DifferentialgeneexpressionwascalculatedaccordingtotheratioinRPKM(readsperkilobaseofexonmodelpermillionmappedreads)
between normal and parthenogenetic cell. Fold change >2 is indicated.
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Imprinted DMRs in Parthenogenetic iPS Cellsnovel imprinted genes (Figure S2F). Notably, of our 21
novel imprinted DMRs (Figure S3) ﬁve are in the Prader-
Willi/Angelman region, two of which are located in the
promoters of known PEGs (NDN and MAGEL2) and are
considered secondary DMRs, resulting from the maternal
gDMRs in this region, and three are novel DMRs residing
in yet-uncharacterized regions of this locus (Figure S4A).
As the complex phenotypes in both Prader-Willi and
Angelman patients are still poorly understood (Mann and
Bartolomei, 1999), it will be of great interest to analyze
the status of these DMRs in patients.
Characterization of Imprinted DMRs Identiﬁes
a Novel Class of Intergenic DMRs
The transcription factor CTCF is a known regulator of
several imprinted loci (Bell and Felsenfeld, 2000; Bell
et al., 1999; Hark et al., 2000). Intriguingly, when we
analyzed chromatin immunoprecipitation sequencing
(ChIP-seq) results of CTCF binding sites in HESCs (Con-
sortium, 2011), we could identify signiﬁcant enrichments
(p value < 1 3 10
 5) for CTCF binding sites in proximity
to many of the novel DMRs (15/21, Figures 2A and S3),
but could not ﬁnd this enrichment for other pluripotent
transcription factors. Using locus-speciﬁc bisulﬁte
sequencing, we conﬁrmed two of the novel DMRs,
WHAMMP3 and TAPPC9, as paternal and maternal
DMRs, respectively (Figure 2B). Studying the stability of
the novel imprinted DMRs in different cell types identiﬁed
that all of the novel DMRs show striking similarities in
methylation levels between HESCs and HiPSCs, but differ
signiﬁcantlyfromthePgHiPSCs(Figures2Cand2D).More-
over, the vast majority of the novel DMRs are highly stable
in both the undifferentiated and differentiated state (Fig-
ure 2E). A notable exception is the newly identiﬁed DMR
in the L3MBTL locus, which similarly to DIRAS3 and
PEG3 shows loss of imprinting following in vitro differen-
tiation (Figure 2E). We next aimed to globally examine
the properties of all imprinted DMRs identiﬁed in this
study (n = 43). Plotting the chromosomal distribution of
all imprinted DMRs elucidates that only a few chromo-
somes lack parental imprinting marks in humans (Fig-
ure 3A). The distribution of DMRs suggests that there are
four genomic clusters of imprinted DMRs (IGF2-H19,
DLK1-DIO3, SNURF-SNRPN, and GNAS loci), which prob-
ably result from differential gene expression (secondary
DMRs) originating from the gDMRs in these loci. Two clus-
ters (chromosomes 11 and 15) are marked by both paternal
and maternal DMRs, while the two other clusters (chromo-
somes 14 and 20) are either complete maternal or paternal.
Close examination of all imprinted DMRs (Figure 3B)
shows that approximately 20% of all DMRs are not associ-
ated with genes (intragenic regions) or gene promoters and
are located in intergenic region (>4 kb of any nearby gene),
a signiﬁcant enrichment to the previously identiﬁed group
of DMRs (Figure S4B). Studying the distance between the
intergenic DMRs to their nearest gene reveals that, unlike
the previously identiﬁed DMRs (Figure S4C), some inter-
genic DMRs are located as far as 10 kb from their nearest
genes (Figure 3C). Moreover, the vast majority of the in-
tergenic DMRs that reside in gene-poor regions are of
paternal origin (pDMRs, Figure 3D), which is in agree-
ment with previous reports (Bartolomei and Ferguson-
Smith, 2011). To link gene expression and DNA
methylation at imprinted DMRs, we analyzed our RNA-
seq data and compared between normal PSCs and
PgHiPSCs. First, we focused on promoter and intragenic
DMRs. This class of imprinted DMRs are predicted to regu-
late the expression of their nearby genes. However, as
some imprinted DMRs were previously shown to affect
genes in cluster (e.g., SNRPN intron-2 DMR), we included
allgenesthatarewithin200kbfromtheDMRs.Comparing
this group of genes to that of all expressed genes in PSCs
shows that most genes that are associated with imprinted
DMRs are downregulated in the PgHiPSCs (Figure 3E; Table
S1). However, few known PEGs (e.g., INPP5F, GRB10, and
MEST), and some putative imprinted genes identiﬁed in
this study, are expressed at high levels in the PgHiPSCs
(TableS1),whiletheirassociateimprintedDMRishyperme-
thylated. This suggests that some of the putative imprinted
genes are tissue speciﬁc and will start to be expressed from
only one of the two parental alleles at a later stage in devel-
opment(FrostandMoore,2010).Itwasrecentlyshownthat
DNA methylation in intragenic regions may serve as alter-
native promoters in a tissue-speciﬁc manner (Maunakea
et al., 2010); it will thus be of interest to study the monoal-
lelic expression of these putative imprinted genes in
different adult tissues. We next examined the group of
novel intergenic imprinted DMRs that are located more
than 10 kb from the nearest gene (Table S2). Here, we
expanded our gene-expression analysis to include genes
that are within 1 Mb of the DMR, in order to allow the
discovery of long-range regulatory effects. Surprisingly,
none of the novel intergenic DMRs had any effect on
geneexpressioninPSCs(Figure3F;TableS2)andthuscould
be classiﬁed as a novel class of intergenic imprinted DMRs.
Altogether, our gene-expression analysis in the pluripotent
state could document only few novel imprinted genes,
suggestingthatsomeofthenovelDMRsmayregulateother
processesbesidegeneexpressionorareregulatedinatissue-
speciﬁc manner.
Comprehensive Comparison between Mouse
and Human Imprinted DMRs
Mice serve as a good model for studying parental
imprinting in humans. We therefore aimed to conduct a
comprehensive comparison between mouse and human
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Imprinted DMRs in Parthenogenetic iPS Cellsimprinted DMRs. We ﬁrst examined mouse DMRs that
were systematically identiﬁed in previous studies,
focusing on DMRs that share synteny between mouse
and human genomes and had sufﬁcient coverage of reads
in our cells. We also studied the corresponding genomic
organization of mouse DMRs in which synteny was par-
tial or not present in the human genome in order to iden-
tify putative human DMRs. Our data suggest that more
than a third of the previously identiﬁed mouse imprinted
DMRs do not have an equivalent DMR in the human
genome (Figure 4A; Table S3). We next took advantage
of a recently established single-base resolution analysis
of DNA methylation in the mouse (Xie et al., 2012), to
compare between mouse novel imprinted DMRs and
the DMRs identiﬁed in our study. Strikingly, our analysis
shows almost half of all imprinted DMRs are species
AB
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Figure 2. Genome-wide Analysis of Imprinted DMRs in PSCs
(A) Regional view of two representative new DMR, TRAPPC9 and WHAMMP3. Average methylation values for wild-type HESCs (blue) and
PgHiPSCs (red) of all CpG calls. Green track indicates the difference between hemimethylated (AMC between 0.3 and 0.7) wild-type PSCs
and PgHiPSCs CpGs. Shownare signiﬁcant putative CTCF bindingsites in H1 EScells from theENCODE project (depicted inblack rectangles,
p value < 1 3 10
 5) and CpG islands (UCSC) in dark-green rectangles. See also Figure S3.
(B) Bisulﬁte sequencing validation of pDMR (WHAMMP3, upper panel) and mDMR (TRAPPC9, lower panel) was conducted on normal
independent PSC not included in the original analysis and PgHiPSCs lines.
(C–E)Methylationvalues(yaxis)±SEinvariouscelltypesacrossthedifferentimprintedDMRs(xaxis);smallarrowspointingtoDMRsthat
are perturbed in the different cell types. (C) Comparison between HESCs and HiPSCs demonstrate the striking similarities between the two
cell types. (D) Comparison between HESCs and the PgHiPSCs showing the differences between the two cell types in methylation values, as
the PgHiPSCs are either hypermethylated (AMC >0.7) or hypomethylated (AMC <0.3) in comparison to hemimethylation state (AMC
between 0.3 and 0.7) of the biparental cells. (E) Analysis of methylation in 16-day-old EBs differentiated from HESCs, demonstrating that
the newly identiﬁed imprintedDMRs are highlystable following in vitrodifferentiation. Notableexception is theDMR inthe L3MBTL locus,
which is consistently hypomethylated in the differentiated cells.
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Imprinted DMRs in Parthenogenetic iPS Cellsspeciﬁc (Figure 4B; Table S3). Genomic synteny analysis
shows that some of the mouse-speciﬁc imprinted DMRs,
such as Commd1/Zrsr1 DMR, lack a syntenic region in hu-
mans (Figure 4C). Since most of the studies so far were
conducted in mouse, only four human-speciﬁc DMRs
were identiﬁed to date. In this study, we could add 17
novel human-speciﬁc DMRs. Close examination of the
data reveals that some of these DMRs may have acquired
the imprint after diverging from the mouse and human
common ancestor, as they share synteny with regions
in which imprinted DMR was not identiﬁed in the mouse
(Figure 4D).
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Figure 3. Characterization of Imprinted DMRs Identiﬁed in This Study
(A) Chromosomal distribution of the 43 imprinted DMRs.
(B) Pie chart representing the different genomic properties of all imprinted DMRs.
(C) Distribution of distances of the imprinted intergenic DMRs to their nearest gene.
(D) Percentage of maternal and paternal DMRs; all DMRs identiﬁed (left bar) and the subset of intergenic DMRs (right panel).
(E and F) Distribution of expression ratios between normal PSCs and PgHiPSCs; x axes represent the log2 fold change between normal PSCs
and PgHiPSCs, and y axes represent the distribution of frequencies for each of the samples; values for individual genes are represented by
small vertical lines on the x axes; Verticals segmented red lines represent 2-fold in expression ratio. (E) Blue, genes associated with
intragenic mDMRs (n = 64); black, all expressed genes (>30 reads, n = 13,223). See also Table S1. (F) Orange, genes associated with
intergenic DMRs (>10 kb from the nearest gene, n = 23); black, all expressed genes.
See also Figure S4 and Table S2.
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In this study, we identiﬁed altogether 21 novel imprinted
DMRs, including a novel class of intergenic DMRs, which
reside in regions with no apparent imprinted genes in
PSCs. This class of imprinted DMRs either may regulate
genes in a tissue-speciﬁc manner, thus adding to
the complexity of parental regulation in the adult tissues,
or these parental marks regulate genes that are yet to
be discovered. Notably, both WHAMMP3 and
LOC100289656, intergenic pDMRs in the Prader-Willi/
Angelmanregion,arelocatedincloseproximitytoacluster
of piRNAs. This class of regulatory small noncoding RNAs
was previously linked with parental imprinting (Watanabe
etal.,2011),andthus it isattractive tosuggestthatthis spe-
ciﬁc cluster of genes is expressed in a monoallelic fashion.
The previously identiﬁed complex three-dimensional orga-
nization of the genome (Lieberman-Aiden et al., 2009) also
suggests that this class of intergenic DMRs may interact
with genes located in remote regions, thus regulating
them in trans. Alternatively, it is plausible that this novel
class of intergenic DMRs regulates other processes beside
gene expression. As it was previously suggested, parental
imprinting may be involved in marking the parental
genomes for recombination (Pardo-Manuel de Villena
et al., 2000). It will thus be of great interest to study
whether these intergenic DMRs may serve as hot spots for
genetic processes such as recombination. The use of mouse
model systems has greatly enhanced our understanding of
parental imprinting. Yet, some genes that are imprinted in
the mouse are not imprinted in the human orthologous
gene (Bartolomei and Ferguson-Smith, 2011). Moreover,
some mouse models fail to recapitulate phenotypes associ-
ated with human-imprinted syndromes (Mann and Barto-
lomei, 1999). Strikingly, our data imply that more than
50% of mouse- and human-imprinted DMRs are species
speciﬁc. In addition, some of these DMRs (e.g., WHAMMP3
and LOC100289656) reside in loci, which are associated
with known human diseases such as Prader-Willi and An-
gelman syndromes. Therefore, our results emphasize the
importance of studying imprinted DMRs in human. In
addition, our analysis identiﬁed that several imprinted
DMRs are consistently perturbed in HESCs and HiPSCs
and thus should be carefully evaluated if these cells are to
be used for clinical applications. Furthermore, as loss of
imprinting was correlated before with different types of
cancers, it will be worthy to study the differential methyl-
ation status of both previously identiﬁed and novel
imprinted DMRs in tumor cell types.
The genomic coverage of RRBS is  10%; however, it
covers the majority of CpG islands (CGIs) and promoters
in the human genome (Harris et al., 2010). As the vast
majority of previously identiﬁed imprinted DMRs reside
A
B
CD
Figure 4. Synteny Analysis between Mouse and Human
Imprinted DMRs
(A) DNA methylation analysis of previously identiﬁed mouse DMRs
in human syntenic regions. See also Table S3.
(B) Vann diagram demonstrating species-speciﬁc imprinted DMRs
in known DMRs (upper panel), and in novel DMRs (lower panel)
identiﬁed either by Xie et al. (2012) (left subset) or in our study
(right subset). Bottom numbers represent the number of species-
speciﬁc DMRs (left and right) and shared DMRs among species. See
also Table S3.
(C and D) (C) Synteny analysis of mouse-speciﬁc DMR in
the Commd1/Zrsr1, and (D) the human-speciﬁc DMRs WHAMMP3
and LOC100289656 that resides in the Prader-Willi/Angelman
region.
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ogy is highly informative for identifying novel imprinted
DMRs throughout the human genome. Future studies,
using whole genome single-base resolution analysis of
DNA methylation, will elucidate whether additional im-
printed DMRs are also present in CpG-poor regions. In
conclusion, we conducted a comprehensive analysis of im-
printed DMRs in humans, identifying multiple novel
DMRs, many of them not associated with gene expression.
Our data shed light on the extent of the phenomenon of
parental imprinting, suggesting that it may play a more
extensive role than was previously thought.
EXPERIMENTAL PROCEDURES
Genomic DNA Isolation
Total genomic DNA was extracted from the parthenogenetic iPS
and teratomacellsusing genomicDNAextraction kit (Real Biotech
Corporation) according to the manufacturer’s protocol.
Reduced Representation Bisulﬁte Sequencing
Reduced representation bisulﬁte sequencing libraries were gener-
ated as previously described in Gu et al. (2011). Raw data were
analyzed using the bioinformatic pipeline described in Bock
et al. (2010).
Bioinformatic Analysis
To identify novel imprinted DMRs throughout the genome, we
searched for hemimethylated regions in both HESCs and HiPSCs
and compared them to the methylation values of the parthenoge-
netic samples (difference between PgHiPSCs and HESCs was
>0.2). A series of ﬁlters was implied in order to avoid false-positive
hits. Speciﬁcally, only regions that exhibited low variation
between all CpGs (SD < 0.2 in at least 60% of the samples for
each cell type) were considered. Further ﬁltering was performed
by verifying high levels of consistency between the samples in
each group (SD for average regional methylation value <0.2).
Next, in order to rule out false DMRs created by aberrant reprog-
ramming (Lister et al., 2011), all regions in which there was no
agreement between PgHiPSCs and their parental ﬁbroblasts
(difference between parthenogenetic and teratoma <0.2) were
ﬁltered out. Next, a more stringent approach was used in order
to conﬁdently identify imprinted DMRs in previously unknown
imprinted regions. Thus, in addition to the above-mentioned
criteria only regions with more than four shared CpGs and with
minimal coverage of ﬁve reads among all samples were used in
this study. As imprinted DMRs are maintained throughout the
development of the embryo, we also looked for hemimethylated
regions in normal ﬁbroblasts. Finally, we included only regions
that met the following criteria: (1) methylation difference
between PgHiPSCs and HESCs >0.2; (2) methylation difference
between PgHiPSCs and HiPSCs >0.15; and (3) methylation
difference between parthenogenetic teratomas and normal
ﬁbroblasts >0.15.
Statistical Analysis
In order to faithfully identify DMRs, all reduced representation
bisulﬁte sequencing (RRBS) regions with missing values were
removed. In addition, as X inactivation results in large-scale differ-
ential methylation between the active and inactive X chromo-
somes both sex chromosomes were removed from the analysis,
leaving 235,080 informative regions. Statistical signiﬁcance of
the identiﬁed DMRs was assessed by random permutations of sam-
ples between groups and recalculation of the average methylation
and statistical values for each region. Permutated data sets were
subject to the same criteria used to identify the DMRs and were
generated until 20 random data sets gave at least the same number
of DMRsas theoriginaldataset. p valuewascalculatedas theprob-
ability of receiving the same number of hits in random data sets.
PCR Bisulﬁte Sequencing
Genomic DNA (2 mg) was bisulﬁte-converted using EZ DNA
methylation-Gold kit (Zymo Research), according to the manufac-
turer’s instructions. PCRs were performed using Faststart Taq DNA
polymerase (Roche) using primers designed to amplify suspected
DMRs. Following ampliﬁcation, PCR products were cleaned using
Gel/PCR DNA fragments extraction kit (Geneaid) and ligated into
pGEM T-Easy vector (Promega) and transformed into DH5a bacte-
ria subjected to white/blue screen. Positive colonies were picked,
and plasmid DNA was extracted for sequencing using Geneaid
high-speed plasmid mini kit (New Taipei City, Taiwan). For a full
list of primers, see primer list in Table 3.
High-Throughput Sequencing
Total RNA was extracted using MirVana microRNA isolation kit
(Ambion Inc) according to the manufacturer’s protocol. Comple-
mentary DNA libraries were established following ribosomal RNA
(rRNA) depletion (RiboMinus Invitrogen). The SOLiD (version
3.5) sequencing system (Life Technologies) was used to generate
35-bp-long reads. Following barcode matching of the samples,
reads were aligned to UCSC complete build (GRCh37/hg19)
genome. All sequences that matched RNA contaminants such as
transfer RNA, rRNA, and DNA repeats were subsequently ﬁltered.
Reads for each transcript was calculated in RPKM (reads per kilo-
base of exon model per million mapped reads) units, to obtain
normalization of the number of reads relative to their transcript
length.
Table 3. Bisulﬁte Sequencing Primer List
DMR Forward Primer Reverse Primer
Bisulﬁte Seq TRAPPC9 GGTTTTAGTAGTATTAGGTA AAACTCTTTACCCTATAAAT
WHAMMP3 GAGATTTTATTTTAAGTATTTA CTAAAACCCAACCCTACTTCTATC
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